pirenzepine has been researched along with Smoking Cessation in 2 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Smoking Cessation: Discontinuing the habit of SMOKING.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wetterling, T | 1 |
Zullino, DF | 1 |
Delessert, D | 1 |
Eap, CB | 1 |
Preisig, M | 1 |
Baumann, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
An Open Label Trial of Ziprasidone as an Adjuvant for Clozapine- or Olanzapine-Associated Diabetes Mellitus or Impaired Fasting Glucose in Chronic Schizophrenia[NCT00351000] | Phase 4 | 24 participants (Actual) | Interventional | 2005-01-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Subjects on clozapine with adjunctive ziprasidone were compared to subjects on olanzapine with adjunctive ziprasidone on change in fasting glucose levels from baseline to study endpoint (week 6 - baseline) (NCT00351000)
Timeframe: baseline, week 6
Intervention | mg/dL (Mean) |
---|---|
Clozapine Treatment With Adjunctive Ziprasidone | 5 |
Olanzapine Treatment With Adjunctive Ziprasidone | -4.5 |
Subjects on clozapine with adjunctive ziprasidone were compared to subjects on olanzapine with adjunctive ziprasidone on change in fasting insulin levels from baseline to study endpoint (week 6 - baseline) (NCT00351000)
Timeframe: baseline, week 6
Intervention | microIU/L (Mean) |
---|---|
Clozapine Treatment With Adjunctive Ziprasidone | 1 |
Olanzapine Treatment With Adjunctive Ziprasidone | -0.9 |
1 review available for pirenzepine and Smoking Cessation
Article | Year |
---|---|
Bodyweight gain with atypical antipsychotics. A comparative review.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Mental Disorders; Olan | 2001 |
1 other study available for pirenzepine and Smoking Cessation
Article | Year |
---|---|
Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Confusion; Cytochro | 2002 |